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Purpose: Surgical treatment of hemodynamically significant carotid artery stenoses has been well documented, especially
in the asymptomatic patient. However, in those patients presenting with hemodynamically significant asymptomatic
carotid artery disease who are to undergo cardiac surgery, optimal treatment remains controversial. In this study, we
analyze our experience with patients who underwent synchronous carotid endarterectomy (CEA) and coronary artery
bypass graft procedures (CABG) for hemodynamically significant (>70%) asymptomatic carotid artery stenosis and
coronary artery disease (CAD).
Methods: Demographics and outcomes of all patients undergoing synchronous CEA/CABG for asymptomatic carotid
stenosis between April 1980 and January 2005 were reviewed from our vascular registry and patient charts. We included
patients who underwent standard patching of their carotid artery and those undergoing eversion CEA. All neurologic
events within the first 30 days that persisted >24 hours were considered a stroke. For purposes of comparison, we also
reviewed outcomes for patients undergoing synchronous CEA/CABG for symptomatic carotid stenosis.
Results: Asymptomatic carotid artery stenosis (>70%) was the indication in 702 patients (276 women and 426 men)
undergoing 758 CEAs. In the asymptomatic group, 22patients, of which 21 succumbed to cardiac dysfunction, and one
died from a hemorrhagic stroke. The overall mortality rate was 3.1%. Seven permanent nonfatal neurologic deficits
occurred in this series (1 woman, 6 men). The combined stroke mortality was 4.3%. This compares to a 30-day stroke
mortality of 6.1% in 132 symptomatic combined CEA/CABG patients. The difference in stroke mortality in women
compared with men was not significant.
Conclusion: In this experience, patients presenting with hemodynamically significant (>70%) asymptomatic carotid
artery stenosis can undergo synchronous CEA/CABG with low morbidity and mortality. ( J Vasc Surg 2006;44:
67-72.)The incidence of major disabling stroke after cardiac
surgery has been well documented.1,2 Yet, despite three
decades of reported experiences, combining carotid endar-
terectomy with coronary artery bypass grafting (CEA/
CABG) still remains controversial.3-8 Only one small pro-
spective trial from The Cleveland Clinic has been
reported.9 This report randomized patients with unilateral
carotid artery stenosis and unstable heart disease to either
synchronous CEA/CABG or a reversed-staged procedure
whereby patients underwent CEA after recovery from their
coronary artery bypass. Patients undergoing a synchronous
procedure had a significantly lower stroke rate than those
undergoing a reversed-staged procedure.
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doi:10.1016/j.jvs.2006.03.031Small series from the 1980s suggested only asymp-
tomatic lesions 90% needed to be addressed during
CABG.10 More contemporary reports also confirm that
patients with significant carotid artery disease can un-
dergo CABG with stroke/mortality rates as low as 1.1%
to 4%.11,12 This, and the absence of any good empirical
data to confirm or refute the efficacy of prophylactic
CEA, led us to re-examine our results for synchronous
procedures in patients with asymptomatic but hemody-
namically significant carotid lesions.
Most of the larger series of CEA/CABG have used the
standard approach to carotid endarterectomy: a vertical
arteriotomy along the common and internal carotid arteries
with either primary closure or patching.3-8 Previous reports
from our center have detailed our overall experience with
synchronous eversion CEA/CABG).13-16 This report deals
with our experience since 1980 in patients with asymptom-
atic carotid artery lesions, the area of greatest concern. We
compared our results with the outcomes for patients un-
dergoing CEA/CABG for symptomatic lesions. We also
compared outcomes over the same period for patients
undergoing primary CEA for asymptomatic stenoses
70%.
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The details of all patients undergoing synchronous
procedures between April 1980 and January 2005 were
retrieved from our vascular registry. The indication for
carotid surgery and the degree of stenosis was recorded.We
analyzed patient demographics and risk factors for athero-
sclerosis. We also identified the incidence of shunt inser-
tion. All intraoperative and postoperative complications
were tabulated, and all neurologic events within the first 30
days identified.
For purposes of definition, neurologic events within
the first 30 days persisting 24 hours were regarded as a
stroke. No attempt was made to differentiate between
major and minor or disabling and nondisabling strokes. In
accordance with the reporting standards of this journal,
stroke mortality was calculated by counting stroke and
death as separate complications; that is, a patient dying
from a postoperative stroke was counted as two events so
the maximum stroke mortality for any series is 200%.
For comparison purposes, data were retrieved on all
patients undergoing elective CEA without CABG over the
same period by the same surgeons, and data were also
retrieved on all symptomatic CEA/CABG patients. Long-
term outcomes were also documented and reinterventions
for recurrent carotid stenosis were recorded. Eversion end-
arterectomy was used in 73% (556/758) of operations, and
standard endarterectomy was used in 27% (202/758).
Standard CEA was the preferred technique in the earlier
period. However, with the adoption of eversion CEA by
our unit for noncardiac carotid surgery, it also became the
technique of choice for synchronous procedures.
Diagnosis. All patients were assessed by cardiologists
and cardiac surgeons for carotid bruits and symptoms re-
ferable to the carotid distribution. Patients with either were
evaluated by duplex ultrasonography, and those asymp-
tomatic patients with 70% stenosis and symptomatic pa-
tients with 50% stenosis were recommended for com-
bined CEA/CABG procedures.
Surgical technique. All procedures were performed
under general anesthesia with full invasive monitoring but
before institution of cardiopulmonary bypass. In no case
was the carotid operation performed under regional block
before general anesthesia. No patients underwent off-pump
bypass.
Dissection of the carotid arteries was usually completed
while the cardiac surgeons harvested leg vein. The patient
was anticoagulated with up to 3,000 U of heparin before
the carotid arteries were cross-clamped. Upon completion
of the carotid surgery, the neck wound was usually left open
to ensure no further bleeding became apparent during full
cardiac anticoagulation. The wound was closed at the end
of the cardiac operation.
Statistical analysis. Statistical comparison of the sur-
gical outcomes for symptomatic and asymptomatic lesions
was performed using a 2 test. All results are mean 
standard deviation.RESULTS
Demographics. Between April 1980 and January 2005,
our unit performed 758 synchronous CEA/CABG proce-
dures for asymptomatic carotid stenosis in 702 patents
(426 men, 276 women; male-female ratio, 1.5:1). The
mean patient age was 69  8.4 (Table I). The difference in
age between men (mean age, 69 8.3) and women (mean
age, 70  8.6) was not significant. A smoking history was
obtained from 259 (36.9%), and 129 patients (18.4%) had
diabetes mellitus. Contralateral occlusions on preoperative
imaging were documented and found in 48 (6.8%) of 702
patients. Synchronous bilateral CEA/CABG operations
were done in 53 patients (see Table II). Three patients had
one side operated immediately before their synchronous
CEA/CABG operation and were therefore included as
bilateral synchronous CEA/CABG operations. In the 758
operations performed for asymptomatic disease, shunts
were used in 26 patients (3.4%).
A further 62 patients underwent a contralateral CEA at
a mean interval of 39  35 months after their CABG, one
of whom died after a major stroke. These 62 operations
were not included as synchronous procedures.
Operative morbidity and mortality. Of the 702 pa-
tientswith asymptomatic lesions, 22died30days of surgery.
The cause of death was cardiac dysfunction in 21 and hemor-
rhagic stroke in one. The overall stroke/mortality rate was
4.3%. Seven nonfatal ischemic strokes occurred in the 702
patients for an overall stroke rate at 30 days of 1.1%. In
addition, nine (1.3%) patients experienced transient neuro-
logic deficits lasting 24 hours (see Table III). No infarct was
identified on axial imaging. Six patients sustained postopera-
tive hematomas that were drained in the operating room: two
on postoperative day 1, and one each on days 2, 4, 9, and 14.
Two patients had recognized early occlusions. One patient
awoke from his CABG with a neurologic deficit. He under-
went immediate re-exploration, thrombectomy, and restora-
tion of blood flow that resulted in resolution of his symptoms.
The other patient had a postoperative cerebrovascular acci-
dent and was not re-explored. The difference in stroke mor-
tality of 4.4% formen and 3.6% for womenwas not significant
(P  NS). Among the 180 patients 75 years, nine died or
had a stroke for a 5% stroke/mortality rate. Among the 522
Table I. Demographic details for 702 asymptomatic
patients undergoing synchronous eversion carotid
endarterectomy and coronary artery bypass grafting
procedures from 1980 to 2005 in Albany*
Men n (%) Women n (%) Total
Procedures 453 (59.7) 305 (40.3) 758
Patients 426 (60.7) 276 (39.3) 702
Mean age 69  8.25 70  8.59 69  8.39
Diabetes mellitus 66 (15.5) 63 (22.8)
Smokers 168 (39.4) 91 (33)
Shunt insertion 18 (3.97) 8 (2.62) 26 (3.43)
*Data are values (%) or mean  SD.patients 75 years, 20 strokes or deaths occurred, including
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mortality rate (P  NS) (see Table IV).
Eversion vs standard CEA. Eversion endarterectomy
was the technique used for 73% (556/758) of CEAs, and
standard endarterectomy was used for 27% (202/758). Six
strokes (one fatal) occurred in the 502 patients undergoing
eversion CEAs for asymptomatic disease, and two strokes
occurred in the 202 patients undergoing standard CEA.
The stroke mortality rate was 1.2% for the eversion tech-
nique and 1% for standard CEA (P  NS).
Long-term outcome.Median follow-up for all asymp-
tomatic patients was 13 months (range, 1 to 213 months).
Nine (1.2%) of the 758 carotid endarterectomies developed
significant restenoses defined by a duplex finding of70%.
Six have undergone repeat carotid endarterectomy, and a
further patient has had a carotid bypass. Two patients are
still being observed in follow-up.
Comparative data. From April 1985 to January 2005,
we also performed synchronous CEA/CABG procedures
in 132 patients with symptomatic carotid artery stenoses.
Their symptoms at time of operation were amaurosis fugax
in 31(24%), transient ischemic attack in 74 (56%), and
recent cerebrovascular accident in 27 (20%). Overall, eight
deaths or strokes occurred in this group for a 6.1% stroke
mortality rate; however, there was no difference in stroke
mortality between the symptomatic and asymptomatic pa-
tients (.05 P .10) although it approached significance.
During this time, our group performed 4803 asymp-
tomatic non-CABG eversion CEAs. There were 71 strokes
or deaths for a combined stroke/mortality rate of 1.5%.
When compared with our asymptomatic CEA/CABG
group, however, the stroke mortality rate in the CABG
patients was significantly greater (P  .001).
Time trends. We tabulated the number of procedures
performed by year. The number of synchronous procedures
rose considerably in 1994; however, after a peak in 1996,
Table II. Clinical outcomes for 53 patients undergoing
bilateral synchronous bilateral synchronous eversion
carotid endarterectomy and coronary artery bypass
grafting operations*
Men Women Total
Bilateral eCEA/CABG
(same operation)
23 30 53
Deaths 1 1 2
Cardiac 1 1 2
Stroke related 0 0 0
Complications 1 1 2
Stroke 0 0 0
Nonfatal cardiac 2 0 2
Hematoma 0 1 1
Bleeding 0 1 1
Restenosis 2 0 2
eCEA, Eversion carotid endarterectomy; CABG, coronary artery bypass
grafting.
*A further 3 patients underwent initial eCEA under regional block followed
by synchronous eCEA/CABGthere has been a steady decline. Our numbers for 2003 and2004 now approach those of 1987 and 1988 (see Fig 1 and
Fig 2).
DISCUSSION
The incidence of hemodynamically significant carotid
artery lesions in patients undergoing elective or emergent
CABG is 2.8% to 7.8%.17,18 Since the first description by
Bernhard et al3 a synchronous procedure in 1972, it has
become routine practice in many centers to perform com-
bined procedures.
Most vascular surgeons’ approach to cardiac patients
with carotid stenosis is influenced by reports from the
1970s and 1980s showing that a patient’s risk of postoper-
ative stroke was directly proportional to the severity of their
carotid disease.1,2 In 1987, Brener et al1 reviewed the
Table III. Clinical outcomes for asymptomatic and
symptomatic patients undergoing synchronous
procedures
Men
n (%)
Women
n (%) Total
Operative mortality 13 (3.05) 9 (3.26) 22 (3.1)
Cardiac causes 12 (2.8) 9 (3.26) 21 (2.99)
Hemorrhagic stroke 1 (0.23) 0 (0) 1 (1.4)
Nonfatal complications
TIA 4 (0.88) 5 (1.64) 9 (1.19)
Stroke 6 (1.32) 1 (0.33) 7 (0.92)
Hematoma 3 (0.66) 3 (0.98) 6 (0.79)
Arterial bleed 0 1 (0.33) 1 (0.13)
Immediate thrombosis 1 (0.22) 0 1 (0.13)
Nerve injury 0 1 (0.33) 1 (0.13)
Respiratory 1 (0.22) 2 (0.66) 3 (0.40)
Cardiac 6 (1.32) 3 (0.98) 9 (1.19)
Restenosis 5 (1.10) 4 (1.31) 9 (1.19)
Being followed-up 1 (0.22) 1 (0.33) 2 (0.26)
Redo CEA 4 (0.88) 2 (0.66) 6 (0.79)
Carotid bypass 0 1 (0.33) 1 (0.13)
Median follow-up
Range (months) 1-213 1-176 1-213
TIA, transient ischemic attack; CEA, carotid endarterectomy.
All data are the value (%) or range.
Table IV. Clinical outcomes for patients aged 75 vs
those for patients 75 years
Men Women Total
Age 75
CEAs 105 82 187
Patients 101 79 180
Stroke/mortality 7 2 9
Age 75
CEAs 348 223 571
Patients 325 197 522
Stroke/mortality 12* 8 20*
CEA, Carotid endarterectomy.
*In keeping with suggested reporting standards, there was a fatal stroke in a
57-year-old man. This is double-counted in the text when calculating
stroke-mortality.outcomes for 4047 patients who underwent carotid evalu-
ue (2
patien
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patients with carotid stenosis 50%, the incidence of sig-
nificant neurologic events was 9.2% compared with 1.9% in
those patients with no carotid disease. A single occluded
carotid conferred a 15.6% risk of stroke, and patients with
bilateral carotid occlusions had a 33% incidence. Others
confirmed this.19
Accordingly, strategies evolved to reduce stroke and
optimize outcomes. These included (1) the staged proce-
dure of CEA followed by CABG, which has a lower stroke
rate but higher rate of myocardial events; (2) the reversed
staged procedure of CABG followed by CEA, which has a
higher incidence of cerebrovascular complications but
fewer cardiac events; and (3) synchronous procedures,
Fig 1. Trends in performance of synchronous carotid
procedures by either eversion (73%) or standard techniq
Fig 2. Comparison of trends in performance of eversio
grafting procedures for symptomatic and asymptomaticwhich have medium incidences of both complications.20However, even reports in the 1970s cautioned that it was
not clear which patients benefited from combined proce-
dures, regardless of permutation. Indeed, the Brener et al
study,1 in addition to detailing the incidence of carotid
disease in cardiac patients, also found that prophylactic
CEA conferred no benefit.
This report reviews our experience with synchronous
CEA with CABG performed during the same operation for
asymptomatic lesions 70% between 1980 and 2005. We
found that CEA can be safely performed for asymptomatic
lesions with a stroke mortality rate of 4.3%. In the earlier
period, standard CEA was used; however, since 1995, we
have only performed 19 standard CEAs for asymptomatic
disease in synchronous patients compared with 545 ever-
rterectomy (CEA) and coronary artery bypass grafting
7%) in Albany from 1980 to 2005.
otid endarterectomy (CEA) and coronary artery bypass
ts in Albany from 1980 to 2005.endan carsion CEAs. Overall, eversion CEA was used in 73% of
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and women, and elderly patients also seemed to benefit as
much as younger patients. This confirms our earlier re-
ported experience with eversion CEA in cardiac patients.16
We also compared our results with those for patients
undergoing synchronous procedures for symptomatic ca-
rotid lesions. The 30-day stroke mortality rate was 6.1% in
our symptomatic combined CEA/CABG patients during
the same period. This was higher than in the asymptomatic
group but did not reach significance (.05  P  0.10). As
symptomatic patients in the non-CABG setting have
greater risks than asymptomatic patients, a small difference
might be expected. As expected, CEA/CABG patients had
a significantly higher stroke mortality rate than non-CABG
or primary CEA patients.
Despite our results, we accept that our opinion on the
safety of synchronous procedures is not universally held. A
recent systematic review of the literature on synchronous
CEA/CABG procedures by Naylor et al21 from the United
Kingdom showed 11.5% of patients died or had a stroke or
myocardial infarction in the perioperative period (95% con-
fidence interval, 10.1 to 12.9).21 Many of the units whose
reports are included in this review had already reported
excellent and very acceptable outcomes for both isolated
CABG and CEA. The implication is that the complication
rates of these two procedures when performed synchro-
nously are multiplicative rather than additive. Equally dis-
concerting is the finding that CABG alone in patients with
unilateral carotid artery stenosis of 50% to 99% is associated
with a 3.1% stroke rate. This includes stroke attributable to
carotid disease as well as other embolic sources. Our stroke
rate for asymptomatic carotid stenoses in this series was
1.1%, but our overall stroke mortality was 4.3%.
Data on Medicare patients in this country from 2003
also refute the idea that outcomes for synchronous proce-
dures are uniform.22 A review of 10,561 CEAs in 10 states
found that the combined stroke mortality rate was 17.7%,
with most of the nonfatal strokes classed as “disabling.”
More disconcerting are contemporary reports of patients
undergoing CABG without prophylactic CEA with accept-
able outcomes.11 A report from Manchester in January
2005 detailed the long-term outcome of 50 patients with
70% carotid stenosis undergoing CABG, half of whom
had severe bilateral disease.12 The stroke mortality rate was
4% at 30 days. However, 27 of the 50 patients in this study
had off-pump bypass, which, it is argued, obviates the need
for prophylactic CEA. Nonetheless, it must be conceded
that these results are similar to ours, regardless of the
stratagem.
A surprising finding on analysis of the number of pro-
cedures performed per annum was a recent tendency to-
wards conservatism. It is not surprising that the number of
CEA/CABGs for asymptomatic carotid artery stenosis rose
appreciably after 1994. Much of this can be attributed to
the publication of the Asymptomatic Carotid Atheroscle-
rosis Study (ACAS) and its application.23 It is a little more
difficult to explain the abrupt decline of the past 5 years,
however. Indeed, our numbers of synchronous proceduresin 2003 to 2004 are similar to those in 1987 to 1988 and
are only a fifth of those performed in 1995. This surprised
us. The advent of coronary stenting may have played a role
in reducing numbers but cannot account for all of it. A
similar trend was also observed for symptomatic disease; so
simple miscoding cannot be an explanation. Could our
cardiology colleagues be having concerns about synchro-
nous procedures?
Undoubtedly, there is a relationship between the ex-
tent of carotid atheroma and stroke in CABG patient that
implicates cerebral hypoperfusion or plaque embolization,
or both. Other factors are involved, however. Aortic arch
disease is present in up to 19.3% of CABG patients and is an
independent predictor of postoperative stroke.24 Patients
with severe aortic arch disease have been shown to have a
5% to 19% risk of perioperative stroke compared with 0% to
2% in patients with relatively healthy aortic arches.21 It has
also been convincingly demonstrated that the degree of
aortic manipulation at the time of surgery directly influ-
ences postoperative stroke rates independent of aortic ath-
erosclerosis.25 Obviously, prophylactic CEA will not bene-
fit these patients from arch emboli. Other factors outside
the control of the surgeon have translated into significant
risk factors for ischemic stroke. A prospective study from
Dartmouth in 2004 of 13,897 patients who underwent
isolated CABG in northern New England from 1992 to
2000 showed that postoperative atrial fibrillation and du-
ration of cardiopulmonary bypass are significant predictors
of embolic and hypoperfusion strokes.26 Again, neither of
these are likely influenced by CEA.
CONCLUSION
In the past, issues of equipoise would have confounded
the idea of a randomized control trial in this area. Empirical
data are clearly needed, however, because the role of CEA in
this setting is now as confused as the role of primary CEAwas
before the North American Symptomatic Carotid Endarter-
ectomy Trial and European Carotid Surgery Trial.27, 28 There
is also the prospect of prophylactic carotid artery stenting,
possibly at time of cardiac catheterization, which will only
serve to further confuse the situation. Although we do not
address the issue here, there may be a subset of patients with
carotid artery disease who benefit most from a synchronous
procedure at the time of coronary revascularization. At the
moment,wehavenomeans of identifying them.However, for
thosewho require a prophylactic procedure, these data at least
provide a benchmark against which other interventions can be
compared.
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